APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccination

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Vaccination Market Outlook and Growth Opportunities 2026

22 December 2025194 pages

Choose your research edition.

Industry ResearchOral Vaccination Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccination Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Oral Vaccination Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccination Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccination Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral Vaccination market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Vaccination is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Vaccination market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Vaccination market include Lanzhou Institute, Tiantan Biological, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech and Serum Institute, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Oral Vaccination market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Vaccination and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Vaccination sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Oral Vaccination market size, projected growth trends, production technologies, key applications, and end-use industries.

Oral Vaccination Segment by Company

Lanzhou Institute

Tiantan Biological

Sanofi

Merck

Shanghai United Cell

GSK

Valneva

Vabiotech

Serum Institute

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

Emergent BioSolutions

Bio-Med

Bibcol

Oral Vaccination Segment by Type

Rotavirus Vaccine

Oral Polio Vaccine

Cholera Vaccine

Other

Oral Vaccination Segment by Application

Public

Private

Oral Vaccination Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Oral Vaccination status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Oral Vaccination market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Vaccination significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Vaccination competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccination market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccination and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccination.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Oral Vaccination market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Vaccination industry.

Chapter 3: Detailed analysis of Oral Vaccination manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Oral Vaccination in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Oral Vaccination in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Vaccination Industry Trends Table 2. Oral Vaccination Industry Drivers Table 3. Oral Vaccination Industry Opportunities and Challenges Table 4. Oral Vaccination Industry Restraints Table 5. Global Oral Vaccination Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Vaccination Revenue Share by Company (2021-2026) Table 7. Global Oral Vaccination Sales Volume by Company (k units) & (2021-2026) Table 8. Global Oral Vaccination Sales Volume Share by Company (2021-2026) Table 9. Global Oral Vaccination Average Price (US$/unit) of Company (2021-2026) Table 10. Global Oral Vaccination Company Ranking, (2024-2026) & (USD Million) Table 11. Global Oral Vaccination Key Company Manufacturing Base & Headquarters Table 12. Global Oral Vaccination Company, Product Type & Application Table 13. Global Oral Vaccination Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Oral Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Rotavirus Vaccine Table 18. Significant Companies of Oral Polio Vaccine Table 19. Significant Companies of Cholera Vaccine Table 20. Significant Companies of Other Table 21. Global Oral Vaccination Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Oral Vaccination Sales Volume by Type (2021-2026) & (k units) Table 23. Global Oral Vaccination Sales Volume by Type (2027-2032) & (k units) Table 24. Global Oral Vaccination Sales Volume Share by Type (2021-2026) Table 25. Global Oral Vaccination Sales Volume Share by Type (2027-2032) Table 26. Global Oral Vaccination Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Oral Vaccination Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Oral Vaccination Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Oral Vaccination Sales Value Share by Type (2021-2026) Table 30. Global Oral Vaccination Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Public Table 32. Significant Companies of Private Table 33. Global Oral Vaccination Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Oral Vaccination Sales Volume by Application (2021-2026) & (k units) Table 35. Global Oral Vaccination Sales Volume by Application (2027-2032) & (k units) Table 36. Global Oral Vaccination Sales Volume Share by Application (2021-2026) Table 37. Global Oral Vaccination Sales Volume Share by Application (2027-2032) Table 38. Global Oral Vaccination Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Oral Vaccination Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Oral Vaccination Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Oral Vaccination Sales Value Share by Application (2021-2026) Table 42. Global Oral Vaccination Sales Value Share by Application (2027-2032) Table 43. Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Oral Vaccination Sales by Region (2021-2026) & (k units) Table 45. Global Oral Vaccination Sales Market Share by Region (2021-2026) Table 46. Global Oral Vaccination Sales by Region (2027-2032) & (k units) Table 47. Global Oral Vaccination Sales Market Share by Region (2027-2032) Table 48. Global Oral Vaccination Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Oral Vaccination Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Oral Vaccination Sales Value Share by Region (2021-2026) Table 51. Global Oral Vaccination Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Oral Vaccination Sales Value Share by Region (2027-2032) Table 53. Global Oral Vaccination Market Average Price (US$/unit) by Region (2021-2026) Table 54. Global Oral Vaccination Market Average Price (US$/unit) by Region (2027-2032) Table 55. Global Oral Vaccination Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Oral Vaccination Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Oral Vaccination Sales by Country (2021-2026) & (k units) Table 58. Global Oral Vaccination Sales Market Share by Country (2021-2026) Table 59. Global Oral Vaccination Sales by Country (2027-2032) & (k units) Table 60. Global Oral Vaccination Sales Market Share by Country (2027-2032) Table 61. Global Oral Vaccination Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Oral Vaccination Sales Value Market Share by Country (2021-2026) Table 63. Global Oral Vaccination Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Oral Vaccination Sales Value Market Share by Country (2027-2032) Table 65. Lanzhou Institute Company Information Table 66. Lanzhou Institute Business Overview Table 67. Lanzhou Institute Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 68. Lanzhou Institute Oral Vaccination Product Portfolio Table 69. Lanzhou Institute Recent Development Table 70. Tiantan Biological Company Information Table 71. Tiantan Biological Business Overview Table 72. Tiantan Biological Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 73. Tiantan Biological Oral Vaccination Product Portfolio Table 74. Tiantan Biological Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Sanofi Oral Vaccination Product Portfolio Table 79. Sanofi Recent Development Table 80. Merck Company Information Table 81. Merck Business Overview Table 82. Merck Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Merck Oral Vaccination Product Portfolio Table 84. Merck Recent Development Table 85. Shanghai United Cell Company Information Table 86. Shanghai United Cell Business Overview Table 87. Shanghai United Cell Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Shanghai United Cell Oral Vaccination Product Portfolio Table 89. Shanghai United Cell Recent Development Table 90. GSK Company Information Table 91. GSK Business Overview Table 92. GSK Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. GSK Oral Vaccination Product Portfolio Table 94. GSK Recent Development Table 95. Valneva Company Information Table 96. Valneva Business Overview Table 97. Valneva Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Valneva Oral Vaccination Product Portfolio Table 99. Valneva Recent Development Table 100. Vabiotech Company Information Table 101. Vabiotech Business Overview Table 102. Vabiotech Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Vabiotech Oral Vaccination Product Portfolio Table 104. Vabiotech Recent Development Table 105. Serum Institute Company Information Table 106. Serum Institute Business Overview Table 107. Serum Institute Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. Serum Institute Oral Vaccination Product Portfolio Table 109. Serum Institute Recent Development Table 110. Panacea Biotec Ltd Company Information Table 111. Panacea Biotec Ltd Business Overview Table 112. Panacea Biotec Ltd Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Panacea Biotec Ltd Oral Vaccination Product Portfolio Table 114. Panacea Biotec Ltd Recent Development Table 115. Halfkin Bio-Pharmaceuticals Company Information Table 116. Halfkin Bio-Pharmaceuticals Business Overview Table 117. Halfkin Bio-Pharmaceuticals Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio Table 119. Halfkin Bio-Pharmaceuticals Recent Development Table 120. EuBiologics Company Information Table 121. EuBiologics Business Overview Table 122. EuBiologics Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. EuBiologics Oral Vaccination Product Portfolio Table 124. EuBiologics Recent Development Table 125. Emergent BioSolutions Company Information Table 126. Emergent BioSolutions Business Overview Table 127. Emergent BioSolutions Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Emergent BioSolutions Oral Vaccination Product Portfolio Table 129. Emergent BioSolutions Recent Development Table 130. Bio-Med Company Information Table 131. Bio-Med Business Overview Table 132. Bio-Med Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Bio-Med Oral Vaccination Product Portfolio Table 134. Bio-Med Recent Development Table 135. Bibcol Company Information Table 136. Bibcol Business Overview Table 137. Bibcol Oral Vaccination Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 138. Bibcol Oral Vaccination Product Portfolio Table 139. Bibcol Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Oral Vaccination Distributors List Table 143. Oral Vaccination Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Oral Vaccination Product Image Figure 2. Global Oral Vaccination Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 4. Global Oral Vaccination Sales (2021-2032) & (k units) Figure 5. Global Oral Vaccination Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Oral Vaccination Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Rotavirus Vaccine Image Figure 10. Oral Polio Vaccine Image Figure 11. Cholera Vaccine Image Figure 12. Other Image Figure 13. Global Oral Vaccination Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Oral Vaccination Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Oral Vaccination Sales Volume Share by Type (2021-2032) Figure 16. Global Oral Vaccination Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Oral Vaccination Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Oral Vaccination Sales Value Share by Type (2021-2032) Figure 19. Public Image Figure 20. Private Image Figure 21. Global Oral Vaccination Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Oral Vaccination Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Oral Vaccination Sales Volume Share by Application (2021-2032) Figure 24. Global Oral Vaccination Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Oral Vaccination Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Oral Vaccination Sales Value Share by Application (2021-2032) Figure 27. Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Oral Vaccination Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Oral Vaccination Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Oral Vaccination Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 32. North America Oral Vaccination Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Oral Vaccination Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Oral Vaccination Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 38. South America Oral Vaccination Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Oral Vaccination Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Oral Vaccination Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Oral Vaccination Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Oral Vaccination Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Oral Vaccination Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Oral Vaccination Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Oral Vaccination Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Oral Polio Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Public
  • Private
Companies covered
  • Lanzhou Institute
  • Tiantan Biological
  • Sanofi
  • Merck
  • Shanghai United Cell
  • GSK
  • Valneva
  • Vabiotech
  • Serum Institute
  • Panacea Biotec Ltd
  • Halfkin Bio-Pharmaceuticals
  • EuBiologics
  • Emergent BioSolutions
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Vaccination Sales Value (2021-2032)
  4. 1.2.2 Global Oral Vaccination Sales Volume (2021-2032)
  5. 1.2.3 Global Oral Vaccination Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Oral Vaccination Market Dynamics
  1. 2.1 Oral Vaccination Industry Trends
  2. 2.2 Oral Vaccination Industry Drivers
  3. 2.3 Oral Vaccination Industry Opportunities and Challenges
  4. 2.4 Oral Vaccination Industry Restraints
3 Oral Vaccination Market by Company
  1. 3.1 Global Oral Vaccination Company Revenue Ranking in 2025
  2. 3.2 Global Oral Vaccination Revenue by Company (2021-2026)
  3. 3.3 Global Oral Vaccination Sales Volume by Company (2021-2026)
  4. 3.4 Global Oral Vaccination Average Price by Company (2021-2026)
  5. 3.5 Global Oral Vaccination Company Ranking (2024-2026)
  6. 3.6 Global Oral Vaccination Company Manufacturing Base and Headquarters
  7. 3.7 Global Oral Vaccination Company Product Type and Application
  8. 3.8 Global Oral Vaccination Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Oral Vaccination Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Oral Vaccination Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Oral Vaccination Market by Type
  1. 4.1 Oral Vaccination Type Introduction
  2. 4.1.1 Rotavirus Vaccine
  3. 4.1.2 Oral Polio Vaccine
  4. 4.1.3 Cholera Vaccine
  5. 4.1.4 Other
  6. 4.2 Global Oral Vaccination Sales Volume by Type
  7. 4.2.1 Global Oral Vaccination Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Oral Vaccination Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Oral Vaccination Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Oral Vaccination Sales Value by Type
  11. 4.3.1 Global Oral Vaccination Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Oral Vaccination Sales Value by Type (2021-2032)
  13. 4.3.3 Global Oral Vaccination Sales Value Share by Type (2021-2032)
5 Oral Vaccination Market by Application
  1. 5.1 Oral Vaccination Application Introduction
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Vaccination Sales Volume by Application
  5. 5.2.1 Global Oral Vaccination Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Vaccination Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Oral Vaccination Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Oral Vaccination Sales Value by Application
  9. 5.3.1 Global Oral Vaccination Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Oral Vaccination Sales Value by Application (2021-2032)
  11. 5.3.3 Global Oral Vaccination Sales Value Share by Application (2021-2032)
6 Oral Vaccination Regional Sales and Value Analysis
  1. 6.1 Global Oral Vaccination Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Vaccination Sales by Region (2021-2032)
  3. 6.2.1 Global Oral Vaccination Sales by Region: 2021-2026
  4. 6.2.2 Global Oral Vaccination Sales by Region (2027-2032)
  5. 6.3 Global Oral Vaccination Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Oral Vaccination Sales Value by Region (2021-2032)
  7. 6.4.1 Global Oral Vaccination Sales Value by Region: 2021-2026
  8. 6.4.2 Global Oral Vaccination Sales Value by Region (2027-2032)
  9. 6.5 Global Oral Vaccination Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Oral Vaccination Sales Value (2021-2032)
  12. 6.6.2 North America Oral Vaccination Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Oral Vaccination Sales Value (2021-2032)
  15. 6.7.2 Europe Oral Vaccination Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Oral Vaccination Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Oral Vaccination Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Oral Vaccination Sales Value (2021-2032)
  21. 6.9.2 South America Oral Vaccination Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Oral Vaccination Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Oral Vaccination Sales Value Share by Country, 2025 VS 2032
7 Oral Vaccination Country-level Sales and Value Analysis
  1. 7.1 Global Oral Vaccination Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Vaccination Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Oral Vaccination Sales by Country (2021-2032)
  4. 7.3.1 Global Oral Vaccination Sales by Country (2021-2026)
  5. 7.3.2 Global Oral Vaccination Sales by Country (2027-2032)
  6. 7.4 Global Oral Vaccination Sales Value by Country (2021-2032)
  7. 7.4.1 Global Oral Vaccination Sales Value by Country (2021-2026)
  8. 7.4.2 Global Oral Vaccination Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Oral Vaccination Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Oral Vaccination Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Oral Vaccination Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Oral Vaccination Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Oral Vaccination Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Oral Vaccination Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Oral Vaccination Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Oral Vaccination Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Oral Vaccination Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Oral Vaccination Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Oral Vaccination Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Oral Vaccination Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Oral Vaccination Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Oral Vaccination Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Oral Vaccination Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Oral Vaccination Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Oral Vaccination Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Oral Vaccination Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Oral Vaccination Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Oral Vaccination Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Oral Vaccination Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Oral Vaccination Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Oral Vaccination Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Oral Vaccination Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Oral Vaccination Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Oral Vaccination Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Oral Vaccination Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Oral Vaccination Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Oral Vaccination Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Oral Vaccination Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Oral Vaccination Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lanzhou Institute
  2. 8.1.1 Lanzhou Institute Company Information
  3. 8.1.2 Lanzhou Institute Business Overview
  4. 8.1.3 Lanzhou Institute Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Lanzhou Institute Oral Vaccination Product Portfolio
  6. 8.1.5 Lanzhou Institute Recent Developments
  7. 8.2 Tiantan Biological
  8. 8.2.1 Tiantan Biological Company Information
  9. 8.2.2 Tiantan Biological Business Overview
  10. 8.2.3 Tiantan Biological Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Tiantan Biological Oral Vaccination Product Portfolio
  12. 8.2.5 Tiantan Biological Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Oral Vaccination Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck Oral Vaccination Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Shanghai United Cell
  26. 8.5.1 Shanghai United Cell Company Information
  27. 8.5.2 Shanghai United Cell Business Overview
  28. 8.5.3 Shanghai United Cell Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanghai United Cell Oral Vaccination Product Portfolio
  30. 8.5.5 Shanghai United Cell Recent Developments
  31. 8.6 GSK
  32. 8.6.1 GSK Company Information
  33. 8.6.2 GSK Business Overview
  34. 8.6.3 GSK Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 GSK Oral Vaccination Product Portfolio
  36. 8.6.5 GSK Recent Developments
  37. 8.7 Valneva
  38. 8.7.1 Valneva Company Information
  39. 8.7.2 Valneva Business Overview
  40. 8.7.3 Valneva Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Valneva Oral Vaccination Product Portfolio
  42. 8.7.5 Valneva Recent Developments
  43. 8.8 Vabiotech
  44. 8.8.1 Vabiotech Company Information
  45. 8.8.2 Vabiotech Business Overview
  46. 8.8.3 Vabiotech Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Vabiotech Oral Vaccination Product Portfolio
  48. 8.8.5 Vabiotech Recent Developments
  49. 8.9 Serum Institute
  50. 8.9.1 Serum Institute Company Information
  51. 8.9.2 Serum Institute Business Overview
  52. 8.9.3 Serum Institute Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Serum Institute Oral Vaccination Product Portfolio
  54. 8.9.5 Serum Institute Recent Developments
  55. 8.10 Panacea Biotec Ltd
  56. 8.10.1 Panacea Biotec Ltd Company Information
  57. 8.10.2 Panacea Biotec Ltd Business Overview
  58. 8.10.3 Panacea Biotec Ltd Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Panacea Biotec Ltd Oral Vaccination Product Portfolio
  60. 8.10.5 Panacea Biotec Ltd Recent Developments
  61. 8.11 Halfkin Bio-Pharmaceuticals
  62. 8.11.1 Halfkin Bio-Pharmaceuticals Company Information
  63. 8.11.2 Halfkin Bio-Pharmaceuticals Business Overview
  64. 8.11.3 Halfkin Bio-Pharmaceuticals Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Halfkin Bio-Pharmaceuticals Oral Vaccination Product Portfolio
  66. 8.11.5 Halfkin Bio-Pharmaceuticals Recent Developments
  67. 8.12 EuBiologics
  68. 8.12.1 EuBiologics Company Information
  69. 8.12.2 EuBiologics Business Overview
  70. 8.12.3 EuBiologics Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 EuBiologics Oral Vaccination Product Portfolio
  72. 8.12.5 EuBiologics Recent Developments
  73. 8.13 Emergent BioSolutions
  74. 8.13.1 Emergent BioSolutions Company Information
  75. 8.13.2 Emergent BioSolutions Business Overview
  76. 8.13.3 Emergent BioSolutions Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Emergent BioSolutions Oral Vaccination Product Portfolio
  78. 8.13.5 Emergent BioSolutions Recent Developments
  79. 8.14 Bio-Med
  80. 8.14.1 Bio-Med Company Information
  81. 8.14.2 Bio-Med Business Overview
  82. 8.14.3 Bio-Med Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Med Oral Vaccination Product Portfolio
  84. 8.14.5 Bio-Med Recent Developments
  85. 8.15 Bibcol
  86. 8.15.1 Bibcol Company Information
  87. 8.15.2 Bibcol Business Overview
  88. 8.15.3 Bibcol Oral Vaccination Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Bibcol Oral Vaccination Product Portfolio
  90. 8.15.5 Bibcol Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Oral Vaccination Value Chain Analysis
  2. 9.1.1 Oral Vaccination Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Oral Vaccination Sales Mode & Process
  6. 9.2 Oral Vaccination Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Oral Vaccination Distributors
  9. 9.2.3 Oral Vaccination Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst